The United Nations recently asked a group of experts across the world to recommend ways to persuade people to take a COVID-19 vaccine. Here is a summary of their suggestions.
Data coming through from phase 3 trials are encouraging. But participants don't represent the whole community — so we can't be sure these vaccines will work as well in everyone.
COVID-19 vaccines are at risk of being undermined by vaccine hesitancy. Pharma must take steps to ensure transparency in data monitoring committees and trial data to build public trust in vaccines.
Governments can't force people to be vaccinated, but they can penalise those who don't.
In the disturbing scenario of human-to-mink-to-human COVID-19 transmission, the virus may mutate in mink prior to re-infecting people. That possibility makes vaccine design even more crucial.
Inaction over the next few months could cost tens of thousands of lives. Here are things you should do now to stay safe and to stop the spread of the coronavirus.
Early data shows that vaccines work for older people who are more at risk of severe COVID-19.
Two pharma companies have announced early COVID-19 vaccine trial results with over 90 per cent effectiveness. What does that mean for getting back to normal?
Asking these four questions can help us identify good news when we see it, be more critical of news reports, or delay our judgement until we have more information.
There are two new COVID-19 vaccines that appear to be more than 90% effective. But what are these vaccines, and how are they different from those used previously?
A private market should have no place in the rollout of a COVID vaccine.
We will struggle to find a vaccine that works perfectly for people who need it most, despite what the headlines say is coming in 2021.
Moderna's shot is far easier to store and distribute than Pfizer's. But there are concerns neither vaccine performs particularly well for older people.
Whatever approach is taken, the vaccine roll-out has to be fair and efficient.
There's no guarantee future COVID-19 vaccines will work in the elderly. So we can consider vaccinating the young first to protect them. Here's what we need to work out first.
Personal stories work better than statistics when it comes to converting sceptics.
Promising vaccines such as Pfizer's will play a role in ending the pandemic – but widespread immunity isn't yet on the horizon.
Watch two of Australia and New Zealand's top vaccine and virus experts answering questions about COVID-19. This was filmed at a Conversation reader event with Avid Reader bookshop.
The Pfizer/BioNTech vaccine may be rolled out in mere weeks.
Side agreements signed by some wealthy nations threaten to undercut global efforts to ensure a fairly equitable worldwide vaccination effort.